Followers | 251 |
Posts | 50193 |
Boards Moderated | 47 |
Alias Born | 08/29/2007 |
Saturday, April 06, 2024 3:52:25 PM
I am writing a book, American Cars of 1958. Check often for the latest addition. https://investorshub.advfn.com/American-Cars-of-1958-37252/
Recent IMCR News
- Form 8-K - Current report • Edgar (US Regulatory) • 05/08/2024 11:13:59 AM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 05/08/2024 11:00:48 AM
- Immunocore reports first quarter financial results and provides a business update • GlobeNewswire Inc. • 05/08/2024 11:00:00 AM
- Immunocore announces upcoming presentation and posters at ASCO 2024 • GlobeNewswire Inc. • 04/24/2024 02:00:00 PM
- Immunocore to present at upcoming investor conferences • GlobeNewswire Inc. • 04/04/2024 08:00:00 PM
- Immunocore presented two posters at CROI 2024 • GlobeNewswire Inc. • 03/05/2024 09:30:00 PM
- Immunocore to present at upcoming investor conferences • GlobeNewswire Inc. • 03/01/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/28/2024 09:19:02 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/28/2024 09:15:31 PM
- Immunocore reports fourth quarter and full year 2023 financial results and provides a business update • GlobeNewswire Inc. • 02/28/2024 12:34:03 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 02/28/2024 12:33:51 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 02/26/2024 11:46:28 PM
- Immunocore announces clinical trial collaboration and supply agreement with Bristol Myers Squibb to evaluate IMC-F106C (PRAME HLA-A02) in combination with nivolumab in its registrational Phase 3 first-line advanced cutaneous melanoma trial • GlobeNewswire Inc. • 02/22/2024 12:00:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:16:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:15:43 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:15:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:15:38 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 02/21/2024 09:15:29 PM
- Immunocore to report fourth quarter and full year 2023 financial results and host call on February 28, 2024 • GlobeNewswire Inc. • 02/21/2024 12:00:00 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 02/02/2024 09:05:00 PM
- Immunocore Prices Upsized Convertible Senior Notes Offering • GlobeNewswire Inc. • 01/31/2024 04:30:00 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/29/2024 10:06:26 PM
- Immunocore Announces Proposed Convertible Senior Notes Offering • GlobeNewswire Inc. • 01/29/2024 09:05:00 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/05/2024 09:17:14 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 01/05/2024 12:19:06 PM
North Bay Resources Announces 50/50 JV at Fran Gold Project, British Columbia; Initiates NI 43-101 Resources Estimate and Bulk Sample • NBRI • May 21, 2024 9:07 AM
Greenlite Ventures Inks Deal to Acquire No Limit Technology • GRNL • May 17, 2024 3:00 PM
Music Licensing, Inc. (OTC: SONG) Subsidiary Pro Music Rights Secures Final Judgment of $114,081.30 USD, Demonstrating Strength of Licensing Agreements • SONGD • May 17, 2024 11:00 AM
VPR Brands (VPRB) Reports First Quarter 2024 Financial Results • VPRB • May 17, 2024 8:04 AM
ILUS Provides a First Quarter Filing Update • ILUS • May 16, 2024 11:26 AM
Cannabix Technologies and Omega Laboratories Inc. enter Strategic Partnership to Commercialize Marijuana Breathalyzer Technology • BLO • May 16, 2024 8:13 AM